Chronic lithium-induced down-regulation of MARCKS in immortalized hippocampal cells: Potentiation by muscarinic receptor activation

Journal of Neurochemistry

Volumn 67, Issue 2, 1996, Pages 767-777

  Watson, David G ^a   Lenox, Robert H ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Carbachol; Hippocampal cells; Inositol; Lithium; MARCKS; Protein kinase C substrate

Indexed keywords

CARBACHOL; DIACYLGLYCEROL; INOSITOL; INOSITOL PHOSPHATE; INOSITOL TRISPHOSPHATE; LITHIUM CHLORIDE; MARCKS PROTEIN; METHYLSCOPOLAMINE; MUSCARINIC RECEPTOR; PHORBOL ESTER; PHOSPHATASE; PHOSPHATIDYLINOSITIDE; PROTEIN KINASE C;

ANIMAL CELL; ARTICLE; BRAIN CELL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DOWN REGULATION; ENZYME ACTIVITY; HIPPOCAMPUS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0030036555     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.67020767.x     Document Type: Article

References (64)

1. Ackermann K. E., Gish B. G., Honchar M. P., and Sherman W. R. (1987) Evidence that inositol 1-phosphate in brain of lithium-treated rats results mainly from phosphatidylinositol metabolism. Biochem J. 242, 517-524.
2. Aderem A. (1992) The MARCKS brothers, a family of protein kinase C substrates. Cell 71, 713-716.
3. Allen L. A. and Aderem A. (1995) Protein kinase C regulates MARCKS cycling between the plasma membrane and lysosomes in fibroblasts. EMBO J. 14, 1109-1120.
4. Allison J. H., Blisner M. W., Holland W. E., Hipps P. P., and Sherman W. R. (1976) Increased brain myo-inositol 1-phosphate in lithium-treated rats. Biochem. Biophys. Res. Commun. 71, 664-670.
5. Atack J. R., Prior A. M., Griffith D., and Ragan C. I. (1993) Characterization of the effects of lithium on phosphatidylinositol (PI) cycle activity in human muscarinic m1 receptor-transfected CHO cells. Br. J. Pharmacol. 110, 809-815.
6. + as secondary, selective, consequences of inositol depletion in 1321N1 cells. Biochem. J. 297, 529-537.
7. Berridge M. J., Downes C. P., and Hanley M. R. (1982) Lithium amplifies agonist dependent phosphatidylinositol responses in brain and salivary glands. Biochem. J. 206, 587-595.
8. Berridge M. J., Downes C. P., and Hanley M. R. (1989) Neural and developmental actions of lithium, a unifying hypothesis. Cell 59, 411-419.
9. 1. J. Biol. Chem. 267, 8081-8088.
10. Bevilacqua J. A., Downes C. P., and Lowenstein P. R. (1994) Visualization of agonist-stimulated inositol phospholipid turnover in individual neurons of the rat cerebral cortex and hippocampus. Neuroscience 60, 945-958.
11. Blackshear P. J. (1988) Approaches to the study of protein kinase C involvement in signal transduction. Am. J. Med. Sci. 296, 231-240.
12. Blackshear P. J. (1993) The MARCKS family of cellular protein kinase C substrates. J. Biol. Chem. 268, 1501-1504.
13. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
14. Brami B. A., Leli U., and Hauser G. (1991) Influence of lithium on second messenger accumulation in NG108-15 cells. Biochem. Biophys. Res. Commun. 174, 606-612.
15. Brami B. A., Leli U., and Hauser G. (1993) Elevated phosphatidyl-CMP is not the source of diacylglycerol accumulation induced by lithium in NG108-I5 cells. J. Neurochem. 60, 1137-1142.
16. Brooks S. F., Herget T., Erusalimsky J. D., and Rozengurt E. (1991) Protein kinase C activation potently down-regulates the expression of its major substrate, 80K, in Swiss 3T3 cells. EMBO J. 10, 2497-2505.
17. 3H] inositol radioactivity and mass of second messenger inositol 1,4,5-trisphosphate in monkey cerebral cortex slices. J. Neurochem. 59, 2332-2335.
18. Downes C. P. and Stone M. A. (1986) Lithium-induced reduction in intracellular inositol supply in cholinergically stimulated parotid gland. Biochem. J. 234, 199-204.
19. Drummond A. H. and Raeburn C. A. (1984) The interaction of lithium with thyrotropin releasing hormone-stimulated lipid metabolism in GH3 pituitary tumor cells. Biochem. J. 224, 129-136.
20. Gani D., Downes C. P., Batty I. H., and Bramham J. (1993) Lithium and myo-inositol homeostasis. Biochim. Biophys. Acta 1177, 253-269.
21. Glanville N. T., Byers D. M., Cook H. W., Spence M. W., and Palmer F. B. St. C. (1989) Differences in the metabolism of inositol and phosphoinositides by cultured cells of neuronal and glial origin. Biochim. Biophys. Acta 1004, 169-179.
22. Godfrey P. P. (1989) Potentiation by lithium of CMP-phosphatidate formation in carbachol-stimulated rat cerebral-cortical slices and its reversal by myo-inositol. Biochem. J. 258, 621-624.
23. Graff J. M., Young T. M., Johnson J. D., and Blackshear P. J. (1989) Phosphorylation-regulated calmodulin binding to a prominent cellular substrate for protein kinase C. J. Biol. Chem. 264, 21818-21823.
24. Gray D. W., Challiss R. A. J., and Nahorski S. R. (1994) Differential effects of lithium on muscarinic cholinoceptor-stimulated CMP-phosphatidate accumulation in cerebellar granule cells, CHO-M3 cells, and SH-SY5Y neuroblastoma cells. J. Neurochem. 63, 1354-1360.
25. Hallcher L. M. and Sherman W. R. (1980) The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J. Biol. Chem. 255, 10896-10901.
26. Hartwig J. H., Thelen M., Rosen A., Janmey P. A., Nairn A. C., and Aderem A. (1992) MARCKS is an actin filament crosslinking protein regulated by protein kinase C and calcium-calmodulin. Nature 356, 618-622.
27. Ishima Y., Fujimagari M., Masuzawa Y., and Waku K. (1993) Inositol 1,4,5-trisphosphate accumulation in brain of lithium-treated rats. Lipids 28, 577-581.
28. 1 muscarinic receptors. Mol. Pharmacol. 46, 1138-1148.
29. Kennedy E. D., Challiss R. A. J., Ragan C. I., and Nahorski S. R. (1990) Reduced inositol polyphosphate accumulation and inositol supply induced by lithium in stimulated cerebral cortex slices. Biochem. J. 267, 781-786.
30. Kim J., Rushovich E. H., Thomas T. P., Ueda T., Agranoff B. W., and Greene D. A. (1991) Diminished specific activity of cytosolic protein kinase C in sciatic nerve of streptozocin-induced diabetic rats and its correction by dietary myo-inositol. Diabetes 40, 1545-1554.
31. Lee H. J., Hammond D. N., Large T. H., Roback J. D., Sim J. A., Brown D. A., Otten U. H., and Wainer B. H. (1990) Neuronal properties and trophic activities of immortalized hippocampal cells from embryonic and young adult mice. J. Neurosci. 10, 1779-1787.
32. Lenox R. H. (1987) Role of receptor coupling to phosphoinositide metabolism in the therapeutic action of lithium, in Advances in Experimental Medicine and Biology, Vol. 221: Molecular Mechanisms of Neuronal Responsiveness (Ehrlich Y., Lenox R. H., Kornecki E., and Berry W. O., eds), pp. 515-530. Plenum Press, New York.
33. Lenox R. H. (1988) Lithium interaction with the phosphoinositide system and protein kinase C in the nervous system, in Progress in Catecholamine Research, Vol. 42 (Belmaker R. H., Sandler M., and Dahlstrom A., eds), pp. 327-335. Alan R. Liss, New York.
34. Lenox R. H. and Manji H. K. (1995) Lithium, in APA Textbook of Psychopharmacology (Nemeroff C. and Schatzberg A., eds), pp. 303-349. APA Press, Washington, DC.
35. Lenox R. H. and Watson D. G. (1994) Lithium and the brain, a psychopharmacological strategy to a molecular basis for manic-depressive illness. Clin. Chem. 40, 309-314.
36. 1-adrenergic response. J. Neurochem. 50, 558-564.
37. Lenox R. H., Watson D. G., Patel J., and Ellis J. (1992) Chronic lithium administration alters a prominent PKC substrate in rat hippocampus. Brain Res. 570, 333-340.
38. Lenox R. H., McNamara R. K., and Watson D. G. (1996) A molecular target for the long-term action of lithium in the brain: a phosphoprotein substrate of protein kinase C, in Mechanisms of Action of Antibipolar Drugs: Focus on Lithium, Carbamazepine and Valproic Acid (Manji H. K., Bowden C., and Belmaker R. H., eds), in press. APA Press, Washington, DC.
39. Levey A. I., Kitt C. A., Simonds W. F., Price D. L., and Brann M. R. (1991) Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J. Neurosci. 11, 3218-3226.
40. Lowry O. H., Rosebrough N. J., Farr A. L., and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
41. Lui J. P., Engler D., Funder J. W., and Robinson P. J. (1994) Arginine vasopressin (AVP) causes the reversible phosphorylation of the myristoylated alanine-rich C kinase substrate (MARCKS) protein in the ovine anterior pituitary: evidence that MARCKS phosphorylation is associated with adrenocorticotropin (ACTH) secretion. Mol. Cell. Endocrinol. 1055, 217-226.
42. Mangels L. A. and Gnegy M. E. (1990) Muscarinic receptor-mediated translocation of calmodulin in SK-N-SH human neuroblastoma cells. Mol. Pharmacol. 37, 820-826.
43. Manji H. K. and Lenox R. H. (1994) Long term action of lithium, a role for transcriptional and posttranscriptional factors regulated by protein kinase C. Synapse 16, 11-28.
44. Manji H. K., Etcheberrigaray R., Chen G., and Olds J. L. (1993) Lithium decreases membrane-associated protein kinase C in hippocampus: selectivity for the α isozyme. J. Neurochem. 61, 2303-2310.
45. Manji H. K., Potter W. Z., and Lenox R. H. (1995) Signal transduction pathways; molecular targets for lithium's action. Arch. Gen. Psychiatry 52, 531-543.
46. Mcllroy B. K., Walters J. D., Blackshear P. J., and Johnson J. D. (1991) Phosphorylation-dependent binding of a synthetic MARCKS peptide to calmodulin. J. Biol. Chem. 266, 4959-4966.
47. Pontremoli S., Mishetti M., Melloni M., Sparatore B., Salamino F., and Horecker B. L. (1990) Identification of the proteolytically activated form of protein kinase C in stimulated human neutrophils. Proc. Natl. Acad. Sci. USA 87, 3705-3707.
48. r 80000 protein, a specific substrate of protein kinase C upon removal of phorbol esters, bombesin and vasopressin. Biochem. Biophys. Res. Commun. 140, 379-385.
49. Rosen A., Keenan K. F., Thelen M., Nairn A. C., and Aderem A. (1990) Activation of protein kinase C results in the displacement of its myristoylated, alanine-rich substrate from punctate structures in macrophage filopodia. J. Exp. Med. 172, 1211-1215.
50. Sawai T., Negishi M., Nishigaki N., Ohno T., and Ichikawa A. (1993) Enhancement by protein kinase C of prostacyclin receptor-mediated activation of adenylate cyclase through a calmodulin/myristoylated alanine-rich C kinase substrate (MARCKS) system in IC2 mast cells. J. Biol. Chem. 268, 1995-2000.
51. Seykora J. T., Ravetch J. V., and Aderem A. (1991) Cloning and molecular characterization of the murine macrophage 68-kDa protein kinase C substrate and its regulation by bacterial lipopolysaccharide. Proc. Natl. Acad. Sci. USA 88, 2505-2509.
52. Sherman W. R., Gish B. G., Honchar M. P., and Munsell L. Y. (1986) Effects of lithium on phosphoinositide metabolism in vivo. Fed. Proc. 45, 2639-2646.
53. Sillence D. and Downes C. P. (1992) Lithium treatment of affective disorders: effects of lithium on the inositol phospholipid and cyclic AMP signaling pathways. Biochim. Biophys. Acta 1138, 46-52.
54. Simek S. L., Kligman D., Patel J., and Colburn N. H. (1989) Differential expression of an 80-kDa protein kinase C substrate in preneoplastic and neoplastic mouse JB6 cells. Proc. Natl. Acad. Sci. USA 86, 7410-7414.
55. q. Science 251, 804-807.
56. Stubbs E. B. and Agranoff B. W. (1993) Lithium enhances muscarinic receptor-stimulated CDP-diacylglycerol formation in inositol-depleted SK-N-SH neuroblastoma cells. J. Neurochem. 60, 1292-1299.
57. Stumpo D. J., Bock C. B., Tuttle J. S., and Blackshear P. J. (1995) MARCKS deficiency in mice leads to abnormal brain development and perinatal death. Proc. Natl. Acad. Sci. USA 92, 944-948.
58. Sun G. Y., Navidi M., Yoa G. G., Lin T. N., Orth O. E., Stubbs E. B., and MacQuarrie R. A. (1992) Lithium effects on inositol phospholipids and inositol phosphates: evaluation of an in vivo model for assessing polyphosphoinositide turnover in brain. J. Neurochem. 58, 290-297.
59. Swierczynski S. L. and Blackshear P. J. (1995) Membrane association of the myristoylated alanine-rich C kinase substrate (MARCKS) protein. Mutational analysis provides evidence for complex interactions. J. Biol. Chem. 270, 13436-13445.
60. Thelen M., Rosen A., Nairn A. C., and Aderem A. (1990) Tumor necrosis factor (α) modifies agonist-dependent responses in human neutrophils by inducing the synthesis and myristoylation of a specific protein kinase C substrate. Proc. Natl. Acad. Sci. USA 87, 5603-5607.
61. Thomas P. T., Talwar H. S., and Anderson W. B. (1988) Phorbol ester-mediated association of protein kinase C to the nuclear fraction of NIH 3T3 cells. Cancer Res. 48, 1910-1919.
62. Wang J. K., Walaas S. I., and Greengard P. (1988) Protein phosphorylation in nerve terminals: comparison of calcium/calmodulin-dependent and calcium/diacylglycerol-dependent systems. J. Neurosci. 8, 281-288.
63. Watson D. G., Wainer B. H., and Lenox R. H. (1994) Phorbol esterand retinoic acid-induced regulation of the protein kinase C substrate MARCKS in immortalized hippocampal cells. J. Neurochem. 63, 1666-1674.
64. 3H] CDP-diacylglycerol in human platelets. Eur. J. Pharmacol. 188, 273-276.